Appeal Bond Cap on the table in New Jersey
John O'Brien • Legal Newsline
Legislation pending in New Jersey would limit the amount a losing party would have to post as a bond for its appeal to $50 million.
John O'Brien • Legal Newsline
Legislation pending in New Jersey would limit the amount a losing party would have to post as a bond for its appeal to $50 million.
Marcus Rayner • Executive Director, NJLRA
NJLRA supports A-2473
Andy Lagomarsino • New Jersey Newsroom
Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance, and Assemblywoman Amy Handlin (R-13), a co-sponsor of A-1982 representing Monmouth County, released the following statement following last week's Assembly Health and Senior Services Committee hearing, which posted the bill for discussion.
Marcus Rayner • Executive Director, NJLRA
Medicine bears the distinction of being both business and personal. Too many promising medical students are becoming a casualty of our litigious health-care system. In turn, it limits the number of specialized medical doctors
Marcus Rayner • Enterprise Magazine, New Jersey Chamber of Commerce
If your company has never been sued, consider yourself lucky. Plaintiffs' attorneys are one group that’s flourishing during this period of 10% unemployment. New Jersey has become a top destination for lawsuits (i.e., t
Marcus Rayner • Executive Director | NJLRA
NJLRA supports A1064, which eliminates the awarding of attorneys' fees for technical violations of the Consumer Fraud Act.
Martin C. Daks and Andrew Kitchenman • NJBiz
Nominee faces tough fight amid political feud
Marcus Rayner • The Record / Op-Ed
According to Forbes Magazine, New Jersey is “one of the worst places to get sued in America.”
Marcus Rayner • The Home News Tribune / To the editor
As Chris Christie prepares to take office on Jan.19, he might want to consider adopting some of the innovative proposals California Gov. Arnold Schwarzenegger has offered to stimulate his state's economy.
John O'Brien • LegalNewsLine.com
ATLANTIC CITY, N.J. (Legal Newsline) - The maker of a popular treatment for severe acne will get a new trial Tuesday, 10 months after the New Jersey Appellate Division struck down a $2.6 million verdict against it.